Kara Beech
|
Posted: 16 Apr 2009 1:39 AM
WYOMING STATE BOARD OF PHARMACY
Board Meeting Agenda
April 29-30, 2009
The Inn at Lander, War Bonnet Room
260 Grand View Drive
Lander, Wyoming
A. Call to Order (
1:00 p.m., Wednesday, April 29, 2009).
1. Review and approval of February 4-5, 2009 Board meeting minutes.
Board membership
B. Presentations to the Board.
1. Wyoming Professional Assistance Program quarterly report.
George A. Vandel, NCAC II, CAP
a. Presentation on assessments and testing.
Executive Director
2.
Long-Term Care Pharmacies
Information Regarding DEA Enforcement Actions Against Bruce McGirr, R.Ph., ASCP Policy and Advocacy News, LTC Manager
April 2, 2009.
Emissary Pharmacy
3. Wyoming Pharmacy Act, Rules and Regulations, Chapter 8:
a. Oxygen suppliers’ inquiry regarding the Rules.
C. Reports to the Board.
1. Legislative report:
Mary K. Walker, R.Ph.
a. SF 0106, regarding the drug donation program.
b. HB 0294, regarding the Prescription Drug Monitoring Program.
2. Budget:
Mary K. Walker, R.Ph.
a. B-11 request status.
b. Budget Information Request memorandum from
Governor Freudenthal, dated February 12, 2009.
c. Executive Order 2009-3: Hiring, Spending Restrictions.
3. Licensing update.
Mary K. Walker, R.Ph.
a. Application for Wyoming Registration as a Wholesale Distributor.
Jacqueline Seebaum
b. Application to Serve as the Designated Representative for a
Wholesale Distributor.
4. Board of Medicine Meeting, February 2009.
Robert J. (Rick) Davis, M.D.
Terry L. Carr, R.Ph.
5. Prescription Drug Monitoring Program report.
Mary K. Walker, R.Ph.
D. Discussion/Action Issues.
1. Supreme Court Opinion 2009 WY 42, dated March 25, 2009, re:
Ken F. Nelson, Esq.
Stuart H. Greene, D.C. v. Wyoming Board of Chiropractic Examiners.
Senior Assistant Attorney General
2. Pharmacists celebrating their golden anniversary of Wyoming licensure:
Board membership
a. Certificate signatures.
b. Certificate presentation discernment.
3. Resolutions for presentation at the NABP® Annual Meeting, May 2009.
Jennifer S. Nevins, R.Ph.
4. Collaborative Practice Committee recommendations.
Jennifer S. Nevins, R.Ph.
5. ePrescribing Task Force report.
Task Force membership
6. Request regarding telepharmacy pharmacist-in-charge.
President, Hoy’s Drug
James K. Massengill, R.Ph.
Wyoming State Board of Pharmacy
Board Meeting Agenda
April 29-30, 2009
Page Two of Two
D. Discussion/Action Issues, continued.
7. Board meeting schedule for 2009:
a. June 24-25, 2009
Ramada Plaza Riverside
Casper, Wyoming
b. September, 2009
Rock Springs, Wyoming
8. Proposed Wyoming Pharmacy Act, Rules and Regulations changes for 2009:
a. Chapter 2: General Practice of Pharmacy Regulations.
b. Chapter 8: Wholesale Distributors.
c. Chapter 12: Institutional Pharmacy Practice Regulations.
d. Chapter 16: Immunization Regulations.
e. Chapter 17: Sterile Compounding.
Timothy S. Seeley, R.Ph.
9. Continuing education audit.
PharmD candidate
Royce Philpott
10. Election of Board officers:
Board membership
a. President.
b. Vice President.
c. Secretary-Treasurer.
E. Informational Items.
1. NABP®
2. Electronic mail message from Tyler J. Brown, Drug Enforcement Administration, dated February 25, 2009.
3.
4.
A White Paper of the Wyoming Pain Initiative, January, 2009.
5.
Report of the Task Force on Standardized Pharmacy Technician Education and Training.Inmates recount the nightmare of long-term addiction. Billings Gazette, February 22, 2009.Recommendations for Improving Pain and Symptom Management in Wyoming:Tramadol listed as Schedule IV Controlled Substance in Kentucky.
6.
NABP® State News Roundup, January, 2009.
7. Excerpts from other state board newsletters with specific disciplinary actions listed by name:
a. New Mexico
b. Colorado
8. Correspondence to BeyondRx from Louann Weber, R.P.T., dated February 12, 2009.
9. Idaho State Board of Pharmacy September, 2008 newsletter excerpt regarding changes to identification
requirements for filling controlled substance prescriptions (Rule 464).
10.
Arizona Board Reiterates Requirements for Counseling on Outpatient Prescriptions,FDA lightens message on drug produced by Cody Laboratories. Wyoming Tribune Eagle, April 12, 2009.
F. Executive Session.
G. Return to Public Meeting.
H. Adjournment.
|